| 1 |
|
Academic Collaborative Centre Limburg: A platform for knowledge transfer and exchange in public health policy, research and practice?
|
Hoeijmakers, M.; Harting, J.; Jansen, M.
|
Elsevier Science B.V., Amsterdam.
|
2013
|
|
|
|
| 2 |
|
An implied term of good faith: watershed or damp squib?
|
Pugh, H.
|
Elsevier Science B.V., Amsterdam.
|
2013
|
|
|
|
| 3 |
|
Authors' response to ''Health service expenditures and efficiencies in Greece'' (I)
|
Vandoros, S.; Stargardt, T.
|
Elsevier Science B.V., Amsterdam.
|
2013
|
|
|
|
| 4 |
|
Authors' response to ''Health service expenditures and efficiencies in Greece'' (II)
|
Kastanioti, C.
|
Elsevier Science B.V., Amsterdam.
|
2013
|
|
|
|
| 5 |
|
Authors' response to ''Health service expenditures and efficiencies in Greece'' (III)
|
Kontodimopoulos, N.
|
Elsevier Science B.V., Amsterdam.
|
2013
|
|
|
|
| 6 |
|
Carey v Urvasco: the application of ``material adverse change'' and ``insolvency event of default'' clauses in the context of a debt rescheduling
|
Hoyle, K.
|
Elsevier Science B.V., Amsterdam.
|
2013
|
|
|
|
| 7 |
|
Consumer credit: a new era approaches
|
Patient, J.
|
Elsevier Science B.V., Amsterdam.
|
2013
|
|
|
|
| 8 |
|
Contents
|
unknown
|
Elsevier Science B.V., Amsterdam.
|
2013
|
|
|
|
| 9 |
|
Cross-border merger regulation: explaining the unexplained
|
Horan, S.; Ballard, A.; Delaney, E.
|
Elsevier Science B.V., Amsterdam.
|
2013
|
|
|
|
| 10 |
|
Developing a national medicines information strategy in Finland-A stakeholders' perspective on the strengths, challenges and opportunities in medicines information
|
Hameen-Anttila, K.; Luhtanen, S.; Airaksinen, M.; Pohjanoksa-Mantyla, M.
|
Elsevier Science B.V., Amsterdam.
|
2013
|
|
|
|
| 11 |
|
Development of a national position paper for chronic care: Example of Belgium
|
Paulus, D.; Van den Heede, K.; Gerkens, S.; Desomer, A.; Mertens, R.
|
Elsevier Science B.V., Amsterdam.
|
2013
|
|
|
|
| 12 |
|
Diagnostic procedures and treatment of childhood obesity by pediatricians: 'The Dutch Approach'
|
Schwiebbe, L.; Talma, H.; van Mil, E. G.; Fetter, W. P.; HiraSing, R. A.; Renders, C. M.
|
Elsevier Science B.V., Amsterdam.
|
2013
|
|
|
|
| 13 |
|
Expanding the role of community pharmacists: Policymaking in the absence of policy-relevant evidence?
|
Mossialos, E.; Naci, H.; Courtin, E.
|
Elsevier Science B.V., Amsterdam.
|
2013
|
|
|
|
| 14 |
|
Health service expenditure and efficiencies in Greece
|
Gourtsoyannis, Y.
|
Elsevier Science B.V., Amsterdam.
|
2013
|
|
|
|
| 15 |
|
Hold your horses: Dutch Supreme Court brings uncertainty to Dutch finance practice
|
van Heerden, E.; Volkers, J.
|
Elsevier Science B.V., Amsterdam.
|
2013
|
|
|
|
| 16 |
|
How effective is an ethical international recruitment policy? Reflections on a decade of experience in England
|
Young, R.
|
Elsevier Science B.V., Amsterdam.
|
2013
|
|
|
|
| 17 |
|
HSH v UBS: lessons from New York
|
Bavoso, V.
|
Elsevier Science B.V., Amsterdam.
|
2013
|
|
|
|
| 18 |
|
International financial institutions' ``no'' to corruption: sanctions regimes, cross-debarments and latest developments
|
Madir, J.
|
Elsevier Science B.V., Amsterdam.
|
2013
|
|
|
|
| 19 |
|
Joint ventures and constructive trusts: where are we now?
|
Tipples, A.
|
Elsevier Science B.V., Amsterdam.
|
2013
|
|
|
|
| 20 |
|
LIBOR: zero floors
|
Kerrigan, C.; Marken, R.
|
Elsevier Science B.V., Amsterdam.
|
2013
|
|
|
|